CAMLIN Fine Sciences Postpones Vinpai Tender Offer

CAMLIN Fine Sciences Limited, an Indian leader in shelf life solutions, announced adjustments to its mandatory tender offer timetable for Vinpai shares. Initially set for mid-December 2025, the filing of a tender offer is now expected by the end of February 2026. This delay results from regulatory processes within India.

On November 27, 2025, CAMLIN completed the acquisition of a 78.68% stake in Vinpai at €3.60 per share. The company now holds 78.68% of Vinpai's capital and 75.06% of its voting rights. The anticipated tender offer aims to acquire remaining Vinpai shares at the same price.

Pending tender procedures, CAMLIN considers a mandatory squeeze-out if untendered shares do not exceed 10% of Vinpai's capital. Meanwhile, convertible bonds issued in October 2025 will increase CAMLIN's stake to 83.82% by year-end.